137 related articles for article (PubMed ID: 2146963)
1. Cytotoxic synergism between trimetrexate and etoposide. Evidence that trimetrexate potentiates etoposide-induced protein-associated DNA strand breaks in L1210 leukemia cells through alterations in intracellular ATP concentrations.
Fry DW
Biochem Pharmacol; 1990 Nov; 40(9):1981-8. PubMed ID: 2146963
[TBL] [Abstract][Full Text] [Related]
2. Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
Kamath N; Grabowski D; Ford J; Ganapathi R
Br J Cancer; 1993 Jun; 67(6):1203-8. PubMed ID: 8099806
[TBL] [Abstract][Full Text] [Related]
3. Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.
Holden SA; Teicher BA; Robinson MF; Northey D; Rosowsky A
Cancer Chemother Pharmacol; 1995; 36(2):165-71. PubMed ID: 7767954
[TBL] [Abstract][Full Text] [Related]
4. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.
Kamath N; Grabowski D; Ford J; Drake F; Kerrigan D; Pommier Y; Ganapathi R
Cancer Commun; 1991 Feb; 3(2):37-44. PubMed ID: 1995027
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
6. Sequence dependent synergistic cytotoxicity between etoposide and fluoropyrimidines.
Damon LE; Christensen S; Rochlitz C; Cadman EC
Anticancer Res; 1989; 9(6):1761-7. PubMed ID: 2534035
[TBL] [Abstract][Full Text] [Related]
7. Modulation of etoposide cytotoxicity and DNA strand scission in L1210 and 8226 cells by polyamines.
Dorr RT; Liddil JD; Gerner EW
Cancer Res; 1986 Aug; 46(8):3891-5. PubMed ID: 3015379
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 2-desamino-2-methyl-10-propagyl-5,8-dideazafolic acid cytotoxicity by 5,10-dideazatetrahydrofolate in L1210 cells with decrease in DNA fragmentation and deoxyadenosine triphosphate pools.
Kwok JB; Tattersall MH
Biochem Pharmacol; 1991 Jul; 42(3):507-13. PubMed ID: 1859463
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of trimetrexate cytotoxicity in vitro and in vivo by carboxypeptidase G2.
Romanini A; Sobrero AF; Chou TC; Sherwood RF; Bertino JR
Cancer Res; 1989 Nov; 49(21):6019-23. PubMed ID: 2529027
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a localized conversion of endogenous tetrahydrofolate cofactors to dihydrofolate as an important element in antifolate action in murine leukemia cells.
Matherly LH; Muench SP
Biochem Pharmacol; 1990 Jun; 39(12):2005-14. PubMed ID: 2141258
[TBL] [Abstract][Full Text] [Related]
11. Enhanced incorporation of 1-beta-D-arabinofuranosylcytosine by pretreatment with etoposide.
Ooi K; Ohkubo T; Kuwabara H; Higashigawa M; Kawasaki H; Kakitoh H; Kagawa Y; Inagaki S; Sumida K; Sakurai M
Cancer Invest; 1993; 11(4):388-92. PubMed ID: 8324643
[TBL] [Abstract][Full Text] [Related]
12. Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
Kerrigan D; Pommier Y; Kohn KW
NCI Monogr; 1987; (4):117-21. PubMed ID: 3041238
[TBL] [Abstract][Full Text] [Related]
13. The influence of radiation and chemotherapy-related DNA strand breaks on carcinogenesis: an evaluation.
Froelich JJ; Schneller FR; Zahn RK
Clin Chem Lab Med; 1999 Apr; 37(4):403-8. PubMed ID: 10369110
[TBL] [Abstract][Full Text] [Related]
14. Compartmentation of intracellular folates. Failure to interconvert tetrahydrofolate cofactors to dihydrofolate in mitochondria of L1210 leukemia cells treated with trimetrexate.
Trent DF; Seither RL; Goldman ID
Biochem Pharmacol; 1991 Aug; 42(5):1015-9. PubMed ID: 1831361
[TBL] [Abstract][Full Text] [Related]
15. [Etoposide-induced deoxyribonucleic acid (DNA) damage and its effects on nucleotide pools in murine leukemia L1210 cells].
Ooi K; Ohkubo T; Kawasaki H; Sakurai M
Yakugaku Zasshi; 1990 Sep; 110(9):673-7. PubMed ID: 2262879
[TBL] [Abstract][Full Text] [Related]
16. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
Yalowich JC; Ross WE
Cancer Res; 1984 Aug; 44(8):3360-5. PubMed ID: 6744270
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interaction between etoposide and 1-beta-D-arabinofuranosylcytosine.
Ohkubo T; Hori H; Higashigawa M; Kawasaki H; Kamiya H; Sakurai M; Kagawa Y; Kakito E; Sumida K; Ooi K
Adv Exp Med Biol; 1989; 253B():355-62. PubMed ID: 2610123
[TBL] [Abstract][Full Text] [Related]
19. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
Yalowich JC; Ross WE
Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
[TBL] [Abstract][Full Text] [Related]
20. Protection from adriamycin cytotoxicity in L1210 cells by brefeldin A.
Vichi PJ; Tritton TR
Cancer Res; 1993 Nov; 53(21):5237-43. PubMed ID: 8106144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
